These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22340395)

  • 41. Antiplatelet treatment does not reduce the severity of subsequent stroke. European Stroke Prevention Study 2 Working Group.
    Sivenius J; Cunha L; Diener HC; Forbes C; Laakso M; Lowenthal A; Smets P; Riekkinen P
    Neurology; 1999 Sep; 53(4):825-9. PubMed ID: 10489049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Computed tomographic brain scans and antiplatelet therapy after stroke: a study of the quality of care in Dutch hospitals.
    van der Meulen JH; Limburg M; van Straten A; Habbema JD
    Stroke; 1996 Apr; 27(4):633-8. PubMed ID: 8614921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Categorized hospital charges of acute ischemic stroke according to trial of org 10172 in acute stroke treatment classification.
    Chang H; Yoon SS; Kwon YD
    Neurol India; 2013; 61(6):633-8. PubMed ID: 24441332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors Influencing Non-Persistence with Antiplatelet Medications in Elderly Patients After Ischaemic Stroke.
    Wawruch M; Zatko D; Wimmer G; Luha J; Kuzelova L; Kukumberg P; Murin J; Hloska A; Tesar T; Kallay Z; Shah R
    Drugs Aging; 2016 May; 33(5):365-73. PubMed ID: 27022917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relevance of living supports on antiplatelet adherence and trial participation: the SPS3 trial.
    Lewis BL; Pearce LA; Field TS; White CL; Benavente OR;
    Int J Stroke; 2014 Jun; 9(4):443-8. PubMed ID: 24661819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The present status of the use of aspirin for secondary prevention of coronary artery disease].
    Liu J; Zhao D; Liu J; Sun JY; Smith SC;
    Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):809-13. PubMed ID: 20079219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post stroke depression among Iranian patients.
    Iranmanesh F; Vakilian A
    Neurosciences (Riyadh); 2009 Apr; 14(2):148-51. PubMed ID: 21048600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study).
    Onozuka D; Hagihara A; Nishimura K; Kada A; Nakagawara J; Ogasawara K; Ono J; Shiokawa Y; Aruga T; Miyachi S; Nagata I; Toyoda K; Matsuda S; Suzuki A; Kataoka H; Nakamura F; Kamitani S; Nishimura A; Kurogi R; Sayama T; Iihara K;
    BMJ Open; 2016 Mar; 6(3):e009942. PubMed ID: 27008684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spontaneous early improvement following ischemic stroke.
    Rothrock JF; Clark WM; Lyden PD
    Stroke; 1995 Aug; 26(8):1358-60. PubMed ID: 7631337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hospital management of acute ischemic stroke in China.
    Chen Z; Sandercock P; Xie JX; Peto R; Collins R; Liu LS
    J Stroke Cerebrovasc Dis; 1997; 6(5):361-7. PubMed ID: 17895034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Patient knowledge about their treatment according to the therapeutic class: misplaced antiplatelet].
    Franchitti J; Desmaizières M; Reuter PG; Galinski M; Adnet F; Lapostolle F
    Presse Med; 2015 Mar; 44(3):354-6. PubMed ID: 25559660
    [No Abstract]   [Full Text] [Related]  

  • 52. Therapeutic Challenges in Patients With Noncardioembolic Acute Ischemic Stroke in Need of Double Antiplatelet Therapy for Coronary Artery Disease: Erratum.
    Am J Ther; 2019; 26(3):e431. PubMed ID: 31082866
    [No Abstract]   [Full Text] [Related]  

  • 53. Evidence-based emergency medicine/systematic review abstract. Antiplatelet agents for acute ischemic stroke.
    Stead LG
    Ann Emerg Med; 2003 Sep; 42(3):423-5. PubMed ID: 12944898
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiplatelet therapy in the treatment and prevention of vascular disease: some clear answers, some new questions.
    Dunbabin D; Sandercock P; Collaboration AT
    Platelets; 1994; 5(1):3-12. PubMed ID: 21043738
    [No Abstract]   [Full Text] [Related]  

  • 55. [The efficacy and safety of antiplatelet monotherapy in patients with ischemic stroke in the real world].
    Liu LP
    Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):324-328. PubMed ID: 30917431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The African American antiplatelet stroke prevention study.
    Weinberger J
    Curr Cardiol Rep; 2004 Mar; 6(2):115. PubMed ID: 14759354
    [No Abstract]   [Full Text] [Related]  

  • 57. Influence of hospital-level practices on readmission after ischemic stroke.
    Neurology; 2015 Jan; 84(3):330. PubMed ID: 25601885
    [No Abstract]   [Full Text] [Related]  

  • 58. Current status of antiplatelet treatment before and after ischemic stroke, and an analysis of factors associated with antiplatelet treatment, in the Qingdao area of China.
    Wang X; Wang P; Yu TF; Zhang M; DU ZQ; Xing CM
    Chin Med J (Engl); 2011 Dec; 124(24):4254-9. PubMed ID: 22340395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prior antiplatelet use and infarct volume in ischemic stroke.
    Ovbiagele B; Buck BH; Liebeskind DS; Starkman S; Bang OY; Ali LK; Villablanca JP; Salamon N; Yun SW; Pineda S; Saver JL
    J Neurol Sci; 2008 Jan; 264(1-2):140-4. PubMed ID: 17854835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of vascular events after ischemic stroke: the China ischemic stroke registry study.
    Ding D; Lu CZ; Fu JH; Hong Z
    Neuroepidemiology; 2010; 34(2):110-6. PubMed ID: 20051694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.